Clinical Trial Update: Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma [Phase 1]

View source ↗

Summary

A phase 1 clinical trial is evaluating glofitamab with obinutuzumab pre-treatment for primary or secondary central nervous system lymphoma, and the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Columvi (glofitamab)
• Gazyva (Obinutuzumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma | Phase 1 | Status: RECRUITING